ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
WisdomTree US Corporate Bond Fund

WisdomTree US Corporate Bond Fund (QIG)

44.0654
0.11
(0.26%)
Closed December 20 4:00PM
44.0654
0.00
( 0.00% )
Pre Market: 8:12AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
44.0654
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
43.9508 52 Week Range 46.23
Market Cap
Previous Close
44.0654
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
698
Shares Outstanding
200,000
Dividend Yield
-
PE Ratio
62.96
Earnings Per Share (EPS)
0.7
Revenue
535k
Net Profit
140k

About WisdomTree US Corporate Bond Fund

The WisdomTree U.S. Corporate Bond Fund (the Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree U.S. Corporate Bond Index (the Index). Under normal circumstances, at least 80% of the funds total assets will be invested in component securities of the ind... The WisdomTree U.S. Corporate Bond Fund (the Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree U.S. Corporate Bond Index (the Index). Under normal circumstances, at least 80% of the funds total assets will be invested in component securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such component securities. The index is designed to capture the performance of selected issuers in the U.S. investment grade corporate bond market that are deemed to have favorable fundamental and income characteristics. The fund is non-diversified. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Headquarters
Wilmington, Delaware, USA
Founded
-
WisdomTree US Corporate Bond Fund is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker QIG. The last closing price for WisdomTree US Corporate was $44.07. Over the last year, WisdomTree US Corporate shares have traded in a share price range of $ 43.9508 to $ 46.23.

WisdomTree US Corporate currently has 200,000 shares outstanding. The market capitalization of WisdomTree US Corporate is $8.81 million. WisdomTree US Corporate has a price to earnings ratio (PE ratio) of 62.96.

QIG Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4546-1.0211141060244.5244.643.9508110744.10384573SP
4-0.2098-0.47385443769944.275245.220643.9508115744.68949764SP
12-1.8046-3.934161761545.874643.950869844.79254481SP
26-0.2298-0.51879210388544.295246.2343.9508100445.22647059SP
52-0.2298-0.51879210388544.295246.2343.9508100445.22647059SP
156-0.2298-0.51879210388544.295246.2343.9508100445.22647059SP
260-0.2298-0.51879210388544.295246.2343.9508100445.22647059SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RELIReliance Global Group Inc
$ 3.95
(229.17%)
34.46M
TRAWTraws Pharma Inc
$ 11.28
(124.70%)
4.71M
GTBPGT Biopharma Inc
$ 3.85
(120.63%)
8.85M
RAPTRAPT Therapeutics Inc
$ 1.4405
(74.52%)
28.42M
EDBLEdible Garden AG Inc
$ 0.3938
(65.67%)
50.06M
AILEiLearningEngines Inc
$ 0.4462
(-49.58%)
631.34k
HSDTHelius Medical Technologies Inc
$ 0.6831
(-24.93%)
736.14k
CDTConduit Pharmaceuticals Inc
$ 0.0577
(-22.76%)
4.68M
WHLMWilhelmina International Inc
$ 3.25
(-21.31%)
3.65k
ONFOOnfolio Holdings Inc
$ 1.26
(-21.25%)
31.11k
EDBLEdible Garden AG Inc
$ 0.3938
(65.67%)
50.06M
RELIReliance Global Group Inc
$ 3.95
(229.17%)
34.46M
RIMEAlgorhythm Holdings Inc
$ 0.0847
(10.86%)
30.92M
RAPTRAPT Therapeutics Inc
$ 1.4405
(74.52%)
28.42M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.5193
(-15.09%)
20.84M

Discussion

View Full Feed
thetinman thetinman 4 minutes ago
Looks like Ptop will deliver the same thing it's delivered to PTOP shareholders for the last 7 years, which is NOTHING and more promises coming with the CEO letter to shareholders next month!! 🤣
PTOP
thesmallguy thesmallguy 4 minutes ago
My response was because I, and a few others, have been waiting over 3 years for a deal here.
ETEK
manibiotech manibiotech 5 minutes ago
Same was said about L 10 years ago . Question is who will be willing to wait another decade 
NWBO
learningcurve2020 learningcurve2020 5 minutes ago
$200,000 plus for a treatment that only shows an alleged 5 year survival advantage beyond SOC in about 5% of patients, and you don't think NICE will have a problem with it?  Unless they can narrow it down to a higher response rate subgroup style="font-size: 1em" that means that about 87% won't respo
NWBO
fredscott36 fredscott36 5 minutes ago
.......OUR - OUR PAYING AGENT............????..................dunno...........

....I was told it was Wilmington Trust.............then......Broadridge, which bought Legent Clearing from Guy.............

.....the BK, our BK cited.............Wellington Management.......
LowFloatLopes LowFloatLopes 5 minutes ago
Christmas Eve eve and your sitting on a board your not invested in? You must have a lot going on in life 😳
NUKK
Cornerstone_Marketing Cornerstone_Marketing 5 minutes ago
https://x.com/adia_nutrition/status/1871185178267410750?s=46&t=ZV-JoM4olm35bFSad3ozrw
ADIA
Paulness Paulness 6 minutes ago
NEWS -- Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial

https://media.zenfs.com/en/globenewswire.com/596a9a524bfac144adaabea16328ae5b

Richland, WA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- – Vivos Inc. (OTCQB: RDGL)
RDGL
Cornerstone_Marketing Cornerstone_Marketing 6 minutes ago
https://x.com/bult_stock/status/1871186576887419158?s=46&t=ZV-JoM4olm35bFSad3ozrw
BULT
Outcast27 Outcast27 6 minutes ago
Looks like a good one...
ONDS
tw0122 tw0122 7 minutes ago
Just need to cure the chickens lol
TRAW
nathanial nathanial 7 minutes ago
Human trials begin in India without submission of the IDE in USA??? Can someone explain to me what's going on??
RDGL
Monksdream Monksdream 7 minutes ago
Top 15 at 9:00
https://ih.advfn.com/markets/nasdaq/premarket
dstock07734 dstock07734 7 minutes ago
You have plenty of shares? You are trying to be funny, are you not?

If you did own many shares, you would at minimum be inquisitive about the DDs posted by many longs. You are just an upgraded version of marty.
NWBO
chemist72 chemist72 8 minutes ago
... trust nobody, and take zero buying and selling advice from any message board.

Well said.
SMCE
mrkirby mrkirby 8 minutes ago
Most penny stocks aren't worth shorting. It's the rate few that get pounded on. That's a fact. You can sort out your own feelings on that statement..
SAPX
adam123 adam123 8 minutes ago
What is the play today guys? ABAT?
ABAT
CherryTree1 CherryTree1 8 minutes ago
I agree . . . unless they are bought out immediately by a Big Pharma Company why sell with DCVAX - Direct directly behind DCVAX-L.
The revenue potential of Direct is almost unimaginable - Merry Christmas

https://investorshub.advfn.com/uimage/uploads/2022/6/7/nuyvlNWBO_DCVAX_Di
NWBO
trunkmonk trunkmonk 8 minutes ago
well im wont wait for schmuck responses or multiple posts to drown out real events...yeah its coming, and its gonna happen soon I believe, no amount of misguided mayhem will change it.

https://www.msn.com/en-us/money/markets/regret-not-buying-bitcoin-at-10-here-are-3-coins-fighting-fo
XRPUSD
slicknick617 slicknick617 8 minutes ago
This thing going up or down today ?
RGTI
manibiotech manibiotech 8 minutes ago
It won't until they are financially secure . As long as they continue to need money on monthly basis they will be shorted . And folks will keep blaming manipulators . That's just how market works . 
Science is only a part of equation which usual few here find very hard to comprehend 
A
AVXL
vg_future vg_future 8 minutes ago
From the PR, I took this as the second one other than JPAD that was discussed here and ST,

Strengthening the submission is the 265 week (~5-year) Phase 2a trial investigating blarcamesine in mild-to-moderate Alzheimer’s disease, with interim preliminary data published in the peer-rev
AVXL
al44 al44 8 minutes ago
Democrats Don’t Transfer Power Peacefully

By J.B. Shurk


Twenty-four years ago, the Clintons left the White House shamefully. Sixteen years later, Obama framed his successor as a Russian spy and laid the groundwork for a coup d’état. Now Biden is itching for nu
Konaploinks Konaploinks 9 minutes ago
45.90. R t q 😎💰🤙
46.05 9:02 rtq
IONQ
joe_techi joe_techi 10 minutes ago
https://www.reuters.com/markets/mexico-warns-trumps-tariff-would-kill-400000-us-jobs-2024-11-27/
AG

Your Recent History

Delayed Upgrade Clock